These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 18651646

  • 1. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
    Jabara R, Chronos N, Robinson K.
    Catheter Cardiovasc Interv; 2008 Aug 01; 72(2):186-94. PubMed ID: 18651646
    [Abstract] [Full Text] [Related]

  • 2. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries.
    Shinke T, Geva S, Pendyala L, Jabara R, Li J, Chen JP, Venegoni A, Colley K, Klein R, Chronos N, Robinson K, Hou D.
    Int J Cardiol; 2009 Jun 12; 135(1):93-101. PubMed ID: 18692915
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
    Jabara R, Chronos N, Conway D, Molema W, Robinson K.
    JACC Cardiovasc Interv; 2008 Feb 12; 1(1):81-7. PubMed ID: 19393150
    [Abstract] [Full Text] [Related]

  • 4. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
    Tada N, Virmani R, Grant G, Bartlett L, Black A, Clavijo C, Christians U, Betts R, Savage D, Su SH, Shulze J, Kar S.
    Circ Cardiovasc Interv; 2010 Apr 12; 3(2):174-83. PubMed ID: 20407114
    [Abstract] [Full Text] [Related]

  • 5. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L, Chen LL, Lin CG, Peng YF, Zheng XC, Luo YK, Zhang FL, Chen JH, Yan XP, Huang ZR.
    Chin Med J (Engl); 2008 Aug 20; 121(16):1518-23. PubMed ID: 18982862
    [Abstract] [Full Text] [Related]

  • 6. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P, Milewski K, Zurakowski A, Pajak J, Liszka Ł, Buszman P, Musioł E, AbuSamra M, Trznadel S, Kałuza G.
    Kardiol Pol; 2010 May 20; 68(5):503-9. PubMed ID: 20491008
    [Abstract] [Full Text] [Related]

  • 7. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA, Mehilli J, Iijima R, Schulz S, Pache J, Seyfarth M, Schömig A, Kastrati A.
    Eur Heart J; 2009 Apr 20; 30(8):923-31. PubMed ID: 19240066
    [Abstract] [Full Text] [Related]

  • 8. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ, Brodeur A, Collingwood R, Ross S, Gibson L, Wang CA, Haller S, Coleman L, Virmani R.
    Catheter Cardiovasc Interv; 2006 Jul 20; 68(1):97-103. PubMed ID: 16755598
    [Abstract] [Full Text] [Related]

  • 9. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
    Jia H, Liu H, Kong J, Hou J, Wu J, Zhang M, Tian J, Liu H, Ma L, Hu S, Huang X, Zhang S, Zhang S, Yu B, Jang IK.
    J Biomed Mater Res A; 2011 Sep 15; 98(4):629-37. PubMed ID: 21732525
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel fully bioabsorbable salicylate-based sirolimus-eluting stent.
    Jabara R, Pendyala L, Geva S, Chen J, Chronos N, Robinson K.
    EuroIntervention; 2009 Dec 15; 5 Suppl F():F58-64. PubMed ID: 22100678
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS, Chen LJ, Chen Z, Ding S, Shen CX, Feng Y.
    Biomed Pharmacother; 2008 Feb 15; 62(2):125-9. PubMed ID: 17764890
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
    Ge J, Qian J, Wang X, Wang Q, Yan W, Yan Y, Fan B, Ge L, Liu X.
    Catheter Cardiovasc Interv; 2007 Feb 01; 69(2):198-202. PubMed ID: 17195205
    [Abstract] [Full Text] [Related]

  • 16. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B, Reddy NK, Karthikeyan G, Raju R, Mishra S, Singh S, Waksman R, Virmani R, Somaraju B.
    Catheter Cardiovasc Interv; 2006 May 01; 67(5):698-702. PubMed ID: 16575925
    [Abstract] [Full Text] [Related]

  • 17. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
    Bhargava B, Karthikeyan G, Shankar PB, Seth S, Singh S, Pr U, Lal AV, Mohanty M.
    Indian Heart J; 2008 May 01; 60(3):228-32. PubMed ID: 19240312
    [Abstract] [Full Text] [Related]

  • 18. Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation.
    Moretti C, Lolli V, Perona G, Vignolini MC, Cabiale K, Falzone M, Galloni M.
    EuroIntervention; 2012 Jan 01; 7(9):1087-94. PubMed ID: 22130128
    [Abstract] [Full Text] [Related]

  • 19. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
    Steigerwald K, Merl S, Kastrati A, Wieczorek A, Vorpahl M, Mannhold R, Vogeser M, Hausleiter J, Joner M, Schömig A, Wessely R.
    Biomaterials; 2009 Feb 01; 30(4):632-7. PubMed ID: 18990438
    [Abstract] [Full Text] [Related]

  • 20. Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.
    Hausleiter J, Kastrati A, Wessely R, Dibra A, Mehilli J, Schratzenstaller T, Graf I, Renke-Gluszko M, Behnisch B, Dirschinger J, Wintermantel E, Schömig A, investigators of the individualizable durg-eluting Stent System to Abrogate Restenosis Project.
    Eur Heart J; 2005 Aug 01; 26(15):1475-81. PubMed ID: 15975990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.